Medical Marijuana, Inc. (OTC: MJNA) CEO Dr. Stuart Titus called in to SmallCapVoice.com to provide the listening audience with his insights into the drivers behind the Company’s largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway. Dr. Titus also provided updates on several of MJNA’s subsidiaries and its major investment AXIM Biotechnologies, Inc. (OTCQB: AXIM).
To see Medical Marijuana, Inc.’s video statement, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are …